Immunotherapy combo could open door to liver transplant for more cancer patients
Disease control
Recruiting now
This study tests whether combining immunotherapy with a liver-directed procedure can safely shrink liver cancer (hepatocellular carcinoma) enough to make patients eligible for a liver transplant. About 41 adults whose cancer is too advanced for current transplant criteria will re…
Phase: PHASE2 • Sponsor: Ju Dong Yang • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC